Using awake prone positioning for patients with acute hypoxic respiratory failure due to pneumonia
Official title: Awake PROne Positioning in PatientS With Acute Hypoxemic Respiratory Failure in Germany - A Randomized Controlled Study
Run by Universitätsklinikum Hamburg-Eppendorf · NCT06931938 · Data updated 2026-11-12
This study is testing if having patients with pneumonia-related breathing problems lie on their stomachs while awake can help them breathe better and reduce the need for breathing tubes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 342 (estimated) |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg, Free and Hanseatic City of Hamburg) |
| Status | Recruiting |
| Started | April 11, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06931938 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include ICU patients diagnosed with acute hypoxemic respiratory failure due to pneumonia.
✕Probably not a fit
Patients under 18 years old, pregnant women, or those unlikely to comply with the study protocol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of awake prone positioning on patients suffering from acute hypoxic respiratory failure (AHRF) due to pneumonia. It aims to determine whether this positioning is more effective than standard supine or semi-recumbent positions in reducing the need for tracheal intubation and all-cause mortality within 28 days. The study will also assess the safety and tolerability of this intervention in an intensive care unit setting. Patients will be monitored closely to evaluate outcomes related to their respiratory function and overall health.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the need for intubation and improve survival rates in patients with AHRF due to pneumonia.
How similar studies have gone: Previous studies have shown positive outcomes with awake prone positioning in intubated patients and those with COVID-19 pneumonia, but conclusive evidence for AHRF patients without COVID-19 is still lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* The focus of this trial is to treat patients with respiratory failure. The inclusion criteria are selected accordingly. Patients meeting all of the criteria listed below will be included in the study:
* Patients in the intensive care unit
* High possibility of Pneumonia (community-acquired pneumonia or hospital-acquired pneumo-nia) either diagnosed by chest x-ray or computed tomography or clinically diagnosed at least with one of the following signs
* Appearance of purulent secretions or changes in characteristics (color, odor, quantity, consistency)
* Cough or dyspnea or tachypnea
* Evocative auscultation
* Presence of acute hypoxemic respiratory failure (PaO2/FIO2 ≤ 300 mmHg or SpO2/FiO2 ≤ 315)
Exclusion Criteria:
* Patients are excluded from the study if any of the following criteria are met at screening or before ran-domization, a detailed list is shown in the study manual:
* Age below 18
* Pregnant woman
* Patient is unlikely/unable to awake prone positioning, or to be compliant as indicated by the treating team
* Prolonged need (≥ 4 days) for HFNO, NIV or CPAP before study inclusion
* Urgent need for endotracheal intubation
* Invasive Mechanical Ventilation
* Shock
o Defined as need for vasopressor ≥ 0.4 mcg/kg/min to maintain a mean blood pressure of ≥ 65 mmHg or systolic blood pressure ≥ 90 mmHg
* Participation in another clinical interventional trial in the last 3 months
* Previous Participation in the PROSA Trial
* Long-term oxygenation therapy (LTOT) or continuous positive airway pressure (CPAP) therapy before hospital admission
* Treatment
Where it's running
-
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, Germany Recruiting
Study contacts
- Principal investigator: Stefan Kluge, MD — Universitätsklinikum Hamburg-Eppendorf
- Study coordinator: Kevin Roedl, MD
- Email: k.roedl@uke.de
- Phone: +49 40 7410 35315
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure using Metabolomics and Clinical Data
This study tests whether metabolomic blood profiles combined with routine clinical data can predict which adults with acute hypoxemic respiratory failure on high-flow nasal cannula will fail and need escalation of care.
-
Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
This study tests whether allowing spontaneous breathing or using controlled ventilation is better for adults with acute hypoxemic respiratory failure who need invasive mechanical ventilation.
-
IL-6 guided dexamethasone or tocilizumab treatment for hospitalized acute hypoxemic respiratory failure
This study will test whether measuring IL-6 to guide early treatment with dexamethasone or tocilizumab helps adults hospitalized with new acute hypoxemic respiratory failure.
-
How changing PEEP affects breathing drive and effort during pressure‑support ventilation
We will test whether changing PEEP levels changes neural respiratory drive and inspiratory effort in adults on pressure‑support ventilation for moderate‑to‑severe ARDS or acute hypoxemic respiratory failure.
-
Intubation strategies for adults with acute hypoxemic respiratory failure
This trial will test two different rules for when to intubate adults with acute hypoxemic respiratory failure to see which approach keeps patients safer while avoiding unnecessary mechanical ventilation.
-
PEEP tuning in acute respiratory failure using CT and EIT data
Researchers will look at routine CT and electrical impedance tomography data from adults on mechanical ventilation to see how different PEEP levels relate to lung information, without any new interventions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.